Your browser doesn't support javascript.
loading
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.
Pesántez, David; Ten Hoorn, Sanne; Machado, Isidro; García-Albéniz, Xabier; Rodríguez-Salas, Nuria; Heredia-Soto, Victoria; Viñal, David; Pericay, Carles; García-Carbonero, Rocio; Losa, Ferran; Alonso, Vicente; Vera, Ruth; Feliu Batlle, Jaime; Gallego, Javier; Salud, Antonieta; Nogué, Miquel; Layos, Laura; Montagut, Clara; Capdevila, Jaume; Vermeulen, Louis; Maurel, Joan; Fernandez-Martos, Carlos.
Affiliation
  • Pesántez D; Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Ten Hoorn S; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Machado I; Department of Medical Oncology, Center for Experimental and Molecular Medicine (CEMM), Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • García-Albéniz X; Department of Medical Oncology, Oncode Institute, Amsterdam, the Netherlands.
  • Rodríguez-Salas N; Department of Pathology, Instituto Valenciano de Oncologia and Pathology Department, Hospital Quirón Salud, Valencia, Spain.
  • Heredia-Soto V; RTI Health Solutions, Barcelona, Spain.
  • Viñal D; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.
  • Pericay C; Translational Oncology Group, IdiPAZ, Madrid, Spain.
  • García-Carbonero R; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Losa F; Department of Medical Oncology, Centro de Investigación Biomédica en Red - Cáncer (CIBERONC), Madrid, Spain.
  • Alonso V; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.
  • Vera R; Translational Oncology Group, IdiPAZ, Madrid, Spain.
  • Feliu Batlle J; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Gallego J; Department of Medical Oncology, Centro de Investigación Biomédica en Red - Cáncer (CIBERONC), Madrid, Spain.
  • Salud A; Department of Medical Oncology, Complex Sanitari Parc Tauli, Sabadell, Spain.
  • Nogué M; Department of Medical Oncology, Complex Sanitari Parc Tauli, Sabadell, Spain.
  • Layos L; Medical Oncology Department. Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Montagut C; Medical Oncology Department, Hospital Sant Joan Despí - Moises Broggi, Barcelona, Spain.
  • Capdevila J; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Vermeulen L; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Maurel J; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.
  • Fernandez-Martos C; Translational Oncology Group, IdiPAZ, Madrid, Spain.
J Natl Cancer Inst ; 115(12): 1497-1505, 2023 12 06.
Article in En | MEDLINE | ID: mdl-37405857
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Neoadjuvant Therapy Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Neoadjuvant Therapy Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Country of publication: